Nanotechnologies – technologies that work with matter on the nanoscale of size between 0.1 nm and 100 nm – have proven potential for impact in advanced fields, including materials, computer technologies, transportation, consumer goods, food, and medicine. While the sector is strongest in North America and Asia currently, Europe is still a leading region for nanotechnology research and development.
The Europe 2020 strategy is the top-level strategic document outlining how European industry can remain strong and competitive in the future while tackling global challenges such as climate change and the impact of a growing population.
In it, nanotechnology is identified as a critical factor in Europe’s successful development as an industrial power.
Globally, research funding for nanotechnologies is growing at a near exponential rate, with European Union member states accounting for nearly a quarter of the total research investment. There are over 4000 nanotechnology companies in the European Union, and research centers in every country across the continent.
What is Nanotechnology?
Nanotechnology is the use of matter on the nanoscale of size in an industrial process. At this scale (below 100 nm), the peculiar laws of quantum mechanics begin to govern interactions between matter. So, nanotechnology can also be defined as the exploitation and application of the discoveries of quantum physics.
This broad definition means that nanotechnology is naturally interdisciplinary. Nanotechnology encompasses research from fields as diverse as molecular engineering, microfabrication, engineering, energy storage, semiconductor physics, molecular biology, organic chemistry, and surface science.
Nanotechnology applications abound in advanced manufacturing and other areas of complicated modern industry. Food technology, medicine and pharmaceuticals, and consumer electronics all rely on developments in nanotechnology to bring everyday products to the market.
Nanotechnology in Europe
Within Europe-wide and state-level policy frameworks, funding priorities, and research ambitions, nanotechnology is seen as a key enabling technology for advanced industry.
It occupies an important place in Europe’s ambitions for a knowledge economy based on cutting-edge innovation both in European industry and the academic community.
This importance is reflected in the specific attention provided to nanotechnology leadership in European Commission funding. For example, a recent fund committed millions of euros to projects achieving industrial leadership for European companies in nanotechnology.
The objective of this funding priority is securing leadership in nanotechnology for European businesses. Nanotechnology is seen as a high-growth global market that can stimulate scientific and technological advances, and nanotechnology investment and adoption generate high value for European economies.
European level funding calls also tend to have a strong focus on responsible development, safety standards, and technological advancement for social benefits.
Phoenix: Europe Wide Nanopharmaceuticals Infrastructure
One example of Europe-wide innovation is the Phoenix project, funded by the European Union’s Horizon 2020 Framework Programme.
The project is developing manufacturing practices that will ensure that nanopharmaceuticals can be developed and deployed effectively from the laboratory to the market – whether the developer is a small business, start-up, research laboratory, or national health organization.
Currently, testing and manufacturing facilities for novel nanopharmaceuticals are unaffordable and inaccessible to all but the largest pharmaceutical corporations with the deepest pockets. This stifles innovation.
As well as developing and deploying best practices for Europe’s nanopharmaceutical industry to ensure the best possible testing and manufacturing processes are followed, the Phoenix project is also creating a new European-level infrastructure that all research centers and laboratories can make use of.
Evaluating Future Nanomaterials’ Performance and Safety
Nanotechnology’s development has given rise to a plethora of new nanomaterials. Many of these have been discovered or developed in Europe, such as graphene, which was first described by scientists working at the University of Manchester (UK).
The next generation of nanomaterials faces a challenge in terms of risk assessment and technology development. Nanoparticles, in particular, display complex behavior that tends to resist the classification and stress testing processes that characterize new materials assessment in larger-scale fields.
To tackle this, a new project coordinated by Helmholtz Zentrum München, Harmless, is creating new tools, guidance, and decision-making support for assessing risk factors in the next generation of nanomaterials.
Subwavelength Nanostructure Research
Nanostructured surfaces manipulate energy and matter around them in unexpected and interesting ways. In nature, nanostructured surfaces include moths’ anti-reflective eyes, lotuses’ self-cleaning leaves, and butterflies’ colorful wings.
In industry, nanostructured surfaces can significantly alter and enhance multiple product types. Reducing reflectivity in photovoltaics, anti-glare properties in automotive parts, and hydrophobic self-cleaning properties for smart packaging all rely on nanostructured surface innovation.
An EU-funded pilot project, Sun Pilot, is developing a new cost-effective platform for making subwavelength nanostructure fabrication methods accessible to Europe’s entire nanotechnology sector.
Large Scale 3D Printing with Nanoscale Control
Large engineering structures like turbines, bridges, and industrial machines, are currently manufactured with traditional, subtractive processes. These techniques do not allow nanoscale control over surface and material features like anti-corrosion and hardness.
A new project, Grade2XL, is developing wire arc additive manufacturing processes for large-scale manufacturing that can have this kind of nanoscale control built-in. The project is being funded by the European Union, with the bulk of work carried out in the Netherlands.
The Future of Nanotechnology in Europe
Nanotechnology will likely become an enabling technology for a diverse range of sectors in Europe in the next few decades. Therefore, strong leadership in nanotechnology in the region will underpin future leadership across industry, research, and development in Europe.
This is especially true for manufacturing. Many analysts argue that a strong manufacturing base is critical to an overall strong economy, and European policymakers see the kind of advanced manufacturing that is enabled by nanotechnology as key to ensuring a future for the regional manufacturing sector.
Nanotechnology will continue to rise in Europe in the next few years, but its growth must be nurtured with strategic policy and funding commitment to ensure the region achieves its potential for numerous and diverse industries well into the twenty-first century.

News
A potential milestone in cancer therapy
Researchers from the University of Bern, Inselspital, University Hospital Bern, and the University of Connecticut have made a significant breakthrough in the fight against cancer. They identified a previously unknown weak point of prostate [...]
Cardiovascular Crystal Ball: New Tool Predicts Future Heart Disease Risk
Faculty members at the UM School of Medicine have created a cutting-edge tool that enables the early identification and assessment of risks in vulnerable patients. Heart disease, being the leading cause of death globally, [...]
Scientists analyze a single atom with X-rays for the first time
In the most powerful X-ray facilities in the world, scientists can analyze samples so small they contain only 10,000 atoms. Smaller sizes have proved exceedingly difficult to achieve, but a multi-institutional team has scaled [...]
AI Demonstrates Superior Performance in Predicting Breast Cancer
AI algorithms outperformed traditional clinical risk models in a large-scale study, predicting five-year breast cancer risk more accurately. These models use mammograms as the single data source, offering potential advantages in individualizing patient care [...]
Stanford Medicine Reveals: Tiny DNA Circles Defying Genetic Laws Drive Cancer Formation
Tiny circles of DNA harbor cancer-associated oncogenes and immunomodulatory genes promoting cancer development. They arise during the transformation from pre-cancer to cancer, say Stanford Medicine-led team. Tiny circles of DNA that defy the accepted laws of [...]
Death to Blood Cancer Cells: New Drug Combination Could Revive the Power of Leading Treatment
Future clinical trials will be conducted to investigate whether the combination of chloroquine and venetoclax can prevent disease recurrence. Although new drugs have been developed to induce cancer cell death in individuals with acute [...]
Illuminating Science: X-Rays Visualize How One of Nature’s Strongest Bonds Breaks
Scientists have deciphered how an activated catalyst breaks down the strong carbon-hydrogen bonds in potent greenhouse gas methane, according to a study published in Science. Using advanced X-ray technology and quantum-chemical calculations, they tracked the [...]
Using magnetic nanoparticles as a rapid test for sepsis
Qun Ren, an Empa researcher, and her team are currently developing a diagnostic procedure that can rapidly detect life-threatening blood poisoning caused by staphylococcus bacteria. Staphylococcal sepsis is fatal in up to 40% of [...]
Team develops nanoparticles to deliver brain cancer treatment
University of Queensland researchers have developed a nanoparticle to take a chemotherapy drug into fast growing, aggressive brain tumors. Research team lead Dr. Taskeen Janjua from UQ's School of Pharmacy said the new silica [...]
Tumor Avatars – A New Approach to Personalized Cancer Treatment
A team from the University of Geneva (UNIGE) has devised a novel method for customizing treatments by testing them on artificial tumors. Determining the optimal treatment for colon cancer can be challenging as each [...]
STING Like a Bee: MIT’s Revolutionary Approach to Cancer Immunotherapy
A cancer vaccine combining checkpoint blockade therapy and a STING-activating drug eliminates tumors and prevents recurrence in mice. MIT researchers have engineered a therapeutic cancer vaccine that targets the STING pathway, vital for immune response [...]
AI Battles Superbugs: Helps Find New Antibiotic Drug To Combat Drug-Resistant Infections
The machine-learning algorithm identified a compound that kills Acinetobacter baumannii, a bacterium that lurks in many hospital settings. Using an artificial intelligence algorithm, researchers at MIT and McMaster University have identified a new antibiotic that can kill a [...]
Cancer and AI – Can ChatGPT Be Trusted?
A study published in the Journal of The National Cancer Institute Cancer Spectrum delved into the increasing use of chatbots and artificial intelligence (AI) in providing cancer-related information. The researchers discovered that these digital resources accurately [...]
Breathing New Life: Oxygen Therapy Improves Heart Function in Long COVID Patients
A small trial has found that hyperbaric oxygen therapy (HBOT) may help restore proper heart function in patients with post-COVID syndrome, with participants in the HBOT group experiencing a significant increase in global longitudinal [...]
Wireless Brain-Spine Interface: A Leap Towards Reversing Paralysis
Summary: In a pioneering study, researchers designed a wireless brain-spine interface enabling a paralyzed man to walk naturally again. The ‘digital bridge’ comprises two electronic implants — one on the brain and another on the [...]
New study reveals a gel that promises to wipe out brain cancer for good
An anti-cancer gel promises to wipe out glioblastoma permanently, a feat that's never been accomplished by any drug or surgery. So what makes this gel so special? Scientists at Johns Hopkins University (JHU) have [...]